| Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner–Wasik M, Tremont–Lukats IW, Sulman EP, Aldape KD, Curran WJ Jr, Mehta MP. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20;370(8):699–708. |
Buckner, J., Pugh, S. L., Shaw, E. G., Gilbert, M., Barger, G., Coons, S., Ricci, P., Bullard, D., Brown, P., Stelzer, K., Brachman, D., Suh, J. H., Schultz, C., Bahary, J.-P., Fisher, B., Kim, H., Murtha, A. D., Curran, W. and Mehta, M.: Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) in Low-Grade Glioma. RTOG 9802 with Alliance, ECOG and SWOG. ASCO, Chicago, IL, May 30, 2014 to June 3, 2014. |
